Cargando…

FLASH Radiotherapy Using Single-Energy Proton PBS Transmission Beams for Hypofractionation Liver Cancer: Dose and Dose Rate Quantification

PURPOSE: This work aims to study the dose and ultra-high-dose rate characteristics of transmission proton pencil beam scanning (PBS) FLASH radiotherapy (RT) for hypofractionation liver cancer based on the parameters of a commercially available proton system operating under FLASH mode. METHODS AND MA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shouyi, Lin, Haibo, Choi, J. Isabelle, Press, Robert H., Lazarev, Stanislav, Kabarriti, Rafi, Hajj, Carla, Hasan, Shaakir, Chhabra, Arpit M., Simone, Charles B., Kang, Minglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794777/ https://www.ncbi.nlm.nih.gov/pubmed/35096620 http://dx.doi.org/10.3389/fonc.2021.813063

Ejemplares similares

Proton Bragg Peak FLASH Enables Organ Sparing and Ultra-High Dose-Rate Delivery: Proof of Principle in Recurrent Head and Neck Cancer
por: Pennock, Michael, et al.
Publicado: (2023)

Dose rate and dose robustness for proton transmission FLASH-RT treatment in lung cancer
por: Wei, Shouyi, et al.
Publicado: (2022)

Quantitative Assessment of 3D Dose Rate for Proton Pencil Beam Scanning FLASH Radiotherapy and Its Application for Lung Hypofractionation Treatment Planning
por: Kang, Minglei, et al.
Publicado: (2021)

A Novel Proton Pencil Beam Scanning FLASH RT Delivery Method Enables Optimal OAR Sparing and Ultra-High Dose Rate Delivery: A Comprehensive Dosimetry Study for Lung Tumors
por: Wei, Shouyi, et al.
Publicado: (2021)

Uncovering the Protective Neurologic Mechanisms of Hypofractionated FLASH Radiotherapy
por: Alaghband, Yasaman, et al.
Publicado: (2023)

Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?
por: Hasan, Shaakir, et al.
Publicado: (2020)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Racial inequity and other social disparities in the diagnosis and management of bladder cancer
por: Hasan, Shaakir, et al.
Publicado: (2022)

Single Ultra-High Dose Rate Proton Transmission Beam for Whole Breast FLASH-Irradiation: Quantification of FLASH-Dose and Relation with Beam Parameters
por: van Marlen, Patricia, et al.
Publicado: (2023)

Lung dose analysis in loco-regional hypofractionated radiotherapy of breast cancer
por: Attar, Mohammad A., et al.
Publicado: (2016)

Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers
por: Press, Robert H., et al.
Publicado: (2021)

Prioritization of Proton Patients in the COVID-19 Pandemic: Recommendations from The New York Proton Center
por: Chhabra, Arpit M., et al.
Publicado: (2020)

Equivalent normalized total dose estimates in cyberknife radiotherapy dose delivery in prostate cancer hypofractionation regimens
por: Sudahar, H., et al.
Publicado: (2012)

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose
por: Hong, ZhengShan, et al.
Publicado: (2023)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
por: Lazo, Antonio, et al.
Publicado: (2022)

Comprehensive Evaluation of Carbon-Fiber-Reinforced Polyetheretherketone (CFR-PEEK) Spinal Hardware for Proton and Photon Planning
por: Shi, Chengyu, et al.
Publicado: (2022)

Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue
por: Press, Robert H, et al.
Publicado: (2023)

Optimal surgical timing and radiotherapy dose for trimodality therapy in locally advanced non‐small cell lung cancer
por: Han, James E., et al.
Publicado: (2021)

Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City
por: Press, Robert H, et al.
Publicado: (2020)

High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
por: HUANG, BING-SHEN, et al.
Publicado: (2013)

Effect of hypofractionation on the incidental axilla dose during tangential field radiotherapy in breast cancer
por: Borm, Kai J., et al.
Publicado: (2020)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
por: Li, Dongqing, et al.
Publicado: (2021)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

FLASH instead of proton arc therapy is a more promising advancement for the next generation proton radiotherapy
por: Kang, Minglei, et al.
Publicado: (2023)

Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Linear Accelerator-Based Stereotactic Radiotherapy for Low-Grade Meningiomas: Improved Local Control With Hypofractionation
por: Wegner, Rodney E, et al.
Publicado: (2019)

Longitudinal Quantitative Analysis of Radiation Oncology Staff Illness in a New York City Center during COVID-19: The Impact of New Guidelines on Operations and Employee Health
por: Hasan, Shaakir, et al.
Publicado: (2020)

Comparison of the dose escalation potential for two hypofractionated radiotherapy regimens for locally advanced pancreatic cancer
por: Bertholet, Jenny, et al.
Publicado: (2019)

Brain metastases: Single-dose radiosurgery versus hypofractionated stereotactic radiotherapy: A retrospective study
por: de la Pinta, Carolina, et al.
Publicado: (2020)

Correlation between Biological Effective Dose and Radiation-induced Liver Disease from Hypofractionated Radiotherapy
por: Bergamo, Angelo M., et al.
Publicado: (2019)

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer: Results From a Multi-Institutional Prospective Registry
por: Eckstein, Jacob, et al.
Publicado: (2023)

Non-conventional Ultra-High Dose Rate (FLASH) Microbeam Radiotherapy Provides Superior Normal Tissue Sparing in Rat Lung Compared to Non-conventional Ultra-High Dose Rate (FLASH) Radiotherapy
por: Wright, Michael D, et al.
Publicado: (2021)

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
por: Wilson, Joseph D., et al.
Publicado: (2020)

Effect of auto flash margin on superficial dose in breast conserving radiotherapy for breast cancer
por: Wang, Lu, et al.
Publicado: (2021)

Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization
por: Kang, Yixiu, et al.
Publicado: (2023)

CBCT-Based Dose Monitoring and Adaptive Planning Triggers in Head and Neck PBS Proton Therapy
por: Reiners, Keaton, et al.
Publicado: (2023)

Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
por: Thomson, David, et al.
Publicado: (2012)

Assessment of MLC tracking performance during hypofractionated prostate radiotherapy using real-time dose reconstruction
por: Fast, M F, et al.
Publicado: (2016)

Immune Response on Optimal Timing and Fractionation Dose for Hypofractionated Radiotherapy in Non–Small-Cell Lung Cancer
por: Zhao, Xianlan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0gco9pp0tun5lfslcpqmktg4gk